LuciBelzu 40mg Tablet (Belzutifan) – Imported | Lucius Pharmaceuticals

Product Overview

LuciBelzu 40mg Tablet is a targeted anticancer medicine containing belzutifan, a hypoxia-inducible factor 2 alpha (HIF-2α) inhibitor. Manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd., this medicine targets a specific biological pathway involved in the growth of certain tumors.

Belzutifan is indicated for eligible adults with von Hippel–Lindau (VHL) disease who require treatment for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET) when immediate surgery is not required.

LuciBelzu 40mg is supplied as a film-coated oral tablet. The listed pack size is 90 tablets. It is a prescription medicine that must be used under the supervision of a qualified oncologist or specialist.

MedicineWalyDost.com provides product information to help customers understand imported medicines, their therapeutic uses, safety precautions, and availability.

Key Product Information

• Brand Name: LuciBelzu
• Generic Name: Belzutifan
• Strength: 40mg
• Dosage Form: Film-coated tablet
• Manufacturer: Lucius Pharmaceuticals (Lao) Co., Ltd.
• Pack Size: 90 tablets
• Product Type: Imported medicine
• Therapeutic Category: Targeted anticancer therapy
• Drug Class: HIF-2α inhibitor
• Route of Administration: Oral
• Primary Indication: Selected VHL-associated tumors
• Availability in Pakistan: Contact MedicineWalyDost.com to confirm current availability, price, and delivery arrangements.

What Is LuciBelzu 40mg Used For?

LuciBelzu contains belzutifan, a targeted medicine used for specific tumors associated with von Hippel–Lindau disease.

1. Von Hippel–Lindau (VHL) Disease

VHL is an inherited condition that can cause cysts and tumors to develop in different parts of the body. Belzutifan may be prescribed to eligible adults who require treatment for associated tumors when immediate surgery is not necessary.

These tumors may include:

• Renal cell carcinoma (RCC): A type of kidney cancer.
• Central nervous system hemangioblastomas: Tumors that may affect the brain or spinal cord.
• Pancreatic neuroendocrine tumors (pNET): Tumors that develop from hormone-producing cells in the pancreas.

The decision to prescribe belzutifan depends on the patient’s diagnosis, tumor characteristics, symptoms, previous treatment, and specialist assessment.

2. Selected Kidney Cancer Treatment

Belzutifan also has approved uses for certain patients with advanced renal cell carcinoma, depending on the applicable product authorization and treatment setting. Eligibility may depend on previous therapies and other clinical factors.

Not every kidney cancer patient is suitable for belzutifan. An oncologist must determine the appropriate treatment based on the patient’s individual circumstances.

How Does LuciBelzu (Belzutifan) Work?

Belzutifan inhibits hypoxia-inducible factor 2 alpha (HIF-2α), a protein that regulates genes involved in the body’s response to low oxygen levels.

In certain tumors, abnormal HIF-2α activity contributes to cancer-cell survival, growth, and progression. By blocking this pathway, belzutifan can interfere with the biological processes that support these tumors.

Unlike conventional chemotherapy, belzutifan is a targeted therapy designed to act on a specific molecular pathway. However, it can still cause serious adverse effects and requires regular medical monitoring.

Dosage and Administration

LuciBelzu 40mg Tablets should be taken exactly as prescribed by the treating specialist.

• For the VHL indication described in the manufacturer’s product information, the recommended adult dose is 120mg once daily.
• A 120mg daily dose corresponds to three 40mg tablets, but the patient’s prescribed dose may differ according to the indication and individual clinical circumstances.
• Tablets may be taken with or without food, according to the product instructions.
• Swallow the tablets whole. Do not crush, chew, or split them unless the official product instructions specifically permit it.
• Take the medicine at approximately the same time each day.
• If you miss a dose or vomit after taking it, follow the official patient leaflet or contact your healthcare professional. Do not take an extra dose to compensate.

Important: The 40mg strength refers to the amount of belzutifan in each tablet, not necessarily the complete daily dose. Never adjust your dose without medical advice.

Possible Side Effects of LuciBelzu 40mg

Like other anticancer medicines, belzutifan can cause side effects. Their severity and frequency vary between patients.

Possible side effects include:

• Anemia or reduced hemoglobin levels
• Fatigue and weakness
• Dizziness
• Headache
• Nausea
• Shortness of breath
• Reduced appetite
• Changes in blood test results

Your healthcare professional may recommend regular blood tests and other assessments to monitor your response to treatment and identify adverse effects early.

Serious Side Effects

Anemia: Belzutifan can reduce hemoglobin levels, lowering the blood’s ability to carry oxygen. Severe anemia may require treatment interruption, dose adjustment, or additional medical care.

Hypoxia: Belzutifan can lower oxygen levels in the blood. Seek urgent medical assessment if you experience new or worsening shortness of breath, severe dizziness, confusion, or bluish lips.

Pregnancy-related risks: Belzutifan may harm an unborn baby. Discuss pregnancy testing and effective contraception with your specialist before starting treatment.

Contact your healthcare professional promptly if you experience severe, persistent, or unexpected symptoms.

Precautions and Warnings

Before starting LuciBelzu 40mg Tablets, inform your doctor about your medical history, current medicines, and any existing health conditions.

Blood Tests and Anemia Monitoring

Belzutifan can cause anemia. Your healthcare team may monitor hemoglobin levels before and during treatment and adjust the treatment plan when necessary.

Oxygen Level Monitoring

Your doctor may assess your blood oxygen levels during treatment. Report breathing difficulties, unusual tiredness, or reduced exercise tolerance promptly.

Pregnancy and Contraception

Belzutifan may cause fetal harm. Patients who could become pregnant should discuss pregnancy testing and effective contraception with their healthcare professional.

Belzutifan may reduce the effectiveness of some hormonal contraceptives. Your doctor may recommend additional or non-hormonal contraception.

Breastfeeding

Discuss breastfeeding with your specialist before starting treatment. Follow the applicable product information regarding breastfeeding during treatment and after the final dose.

Existing Medical Conditions

Tell your doctor if you have anemia, low blood oxygen levels, kidney or liver problems, or any other significant medical condition.

Drug Interactions

Belzutifan can interact with other medicines and may affect the effectiveness of certain treatments, including some hormonal contraceptives.

Before starting LuciBelzu, provide your doctor or pharmacist with a complete list of:

• Prescription medicines
• Over-the-counter medicines
• Vitamins and nutritional supplements
• Herbal products
• Hormonal contraceptives
• Other cancer treatments

Do not start, stop, or change any medicine without consulting your healthcare professional.

Who Should Use LuciBelzu 40mg Tablets?

LuciBelzu may be appropriate for eligible adults with VHL-associated tumors who meet the relevant treatment criteria.

A qualified oncologist or specialist must evaluate the patient’s diagnosis, medical history, previous treatments, laboratory results, and potential risks before prescribing belzutifan.

This medicine is not intended for self-medication. It should only be used for an appropriate medical indication under professional supervision.

Storage Instructions

• Store according to the manufacturer’s instructions.
• The manufacturer’s product information specifies storage in a dry place at 20°C to 25°C.
• Keep the tablets in their original packaging where appropriate.
• Keep the medicine out of the reach of children.
• Do not use expired tablets or damaged packaging.
• Ask a pharmacist about the safe disposal of unused medicine.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com helps customers explore information about imported medicines and enquire about product availability.

• Product information: Learn about belzutifan, its strength, and therapeutic uses.
• Imported medicine enquiries: Ask about LuciBelzu 40mg Tablet availability.
• Pack-size details: The listed pack contains 90 tablets.
• Price enquiries: Contact the team for current pricing and stock information.
• Prescription guidance: Confirm prescription requirements before purchasing.

For specialist cancer medicines, always verify the product’s authenticity, packaging, manufacturer details, and regulatory status with a qualified pharmacist or healthcare professional.

Frequently Asked Questions (FAQs)

1. What is LuciBelzu 40mg Tablet used for?

LuciBelzu contains belzutifan, a targeted anticancer medicine used for certain tumors associated with von Hippel–Lindau disease and other eligible conditions covered by the applicable product authorization.

2. Who manufactures LuciBelzu 40mg Tablets?

The product is listed as manufactured and marketed by Lucius Pharmaceuticals (Lao) Co., Ltd. Confirm the manufacturer details on the supplied packaging.

3. What is the pack size of LuciBelzu 40mg?

The listed pack size is 90 tablets. Verify the pack configuration and packaging before purchase.

4. How does belzutifan work?

Belzutifan inhibits HIF-2α, a protein involved in biological pathways that can support tumor growth. Blocking this protein can help control the progression of certain tumors.

5. What is the recommended dose of LuciBelzu?

For the VHL indication described in the manufacturer’s product information, the recommended adult dose is 120mg once daily. The correct dose depends on the prescribed indication and the patient’s circumstances.

6. What are the main side effects of LuciBelzu?

Important side effects include anemia, fatigue, dizziness, and low blood oxygen levels. Regular medical monitoring is essential during treatment.

7. Can LuciBelzu be taken without a prescription?

No. Belzutifan is a prescription anticancer medicine that requires specialist supervision and appropriate monitoring.

8. How can I check the price of LuciBelzu 40mg in Pakistan?

Contact MedicineWalyDost.com to confirm the current price, product availability, prescription requirements, and delivery arrangements.

Conclusion

LuciBelzu 40mg Tablet (Belzutifan) is a targeted anticancer medicine manufactured by Lucius Pharmaceuticals. It inhibits HIF-2α and is used for selected tumor conditions, including certain VHL-associated tumors, under specialist medical supervision.

The listed pack size is 90 tablets. Because belzutifan can cause anemia and reduced blood oxygen levels, regular medical monitoring is essential throughout treatment.

For product enquiries, contact MedicineWalyDost.com to confirm current availability, pricing, packaging details, and prescription requirements before purchase.